Khiron Life Sciences Corp V.KHRN.H

RE:RE:RE:Q1 May 28th + New PR Agreement

[Benedictus]

I'm not discounting the long term potential of Khiron as they continue their clinic buildout, script issuance growth and expand strong Latam brand recognition. But to suggest any credible analyst would suggest this company is worth $3 a share or a 600M fully diluted market cap in a few months is frankly ludicrous. For reference, a 600M market cap would be even higher than the pre private placement blowoff top when shares traded well over $4 per share, during the height of marijuana mania. Important milestones will be in the coming quarters as this company finally starts to erode the ongoing massive quarterly cash burn to mitigate the possibility of another dilution event. They have built a solid foundation and are now executing very strongly but early successes in Columbia does not at all equate to Latam domination.